Rethinking the Clinically Based Thresholds of TransCelerate BioPharma for Risk-Based Monitoring

被引:0
|
作者
Richard C. Zink
Anastasia Dmitrienko
Alex Dmitrienko
机构
[1] SAS Institute Inc,JMP Life Sciences
[2] University of North Carolina at Chapel Hill,Department of Biostatistics
[3] Columbia University,Data Management and Statistics
[4] Mediana Inc,undefined
[5] Target PharmaSolutions,undefined
来源
Therapeutic Innovation & Regulatory Science | 2018年 / 52卷
关键词
Data visualization; exposure-adjusted; risk-based approaches; statistical monitoring; time windows;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:560 / 571
页数:11
相关论文
共 50 条